VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Male and female patients, age 18-75 yrs            │ Male and female patients, age 18-75 yrs            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Written informed consent                           │ Written informed consent                           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Comorbidities such as uncontrolled cardiovascular  │ Comorbidities such as uncontrolled cardiovascular  │     100 │
│ disease, i.e., unstable systemic arterial          │ disease, i.e., unstable systemic arterial          │         │
│ hypertension, coronary artery disease; previous    │ hypertension, coronary artery disease; previous    │         │
│ stroke; OSA; pneumothorax in the last 2 months     │ stroke; OSA; pneumothorax in the last 2 months     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Internal, neurologic, rheumatologic or psychiatric │ Internal, neurologic, rheumatologic or psychiatric │     100 │
│ disease including current heavy smoking (\>20      │ disease including current heavy smoking (>20       │         │
│ cigarettes per day)                                │ cigarettes per day)                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known renal failure or allergy to acetazolamide    │ Known renal failure or allergy to acetazolamide    │     100 │
│ and other sulfonamides                             │ and other sulfonamides                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ COPD diagnosed according to GOLD, FEV1 40-80%      │ COPD diagnosed according to GOLD, FEV1 40-80%      │      99 │
│ predicted, SpO2 ≥92% at 750 m                      │ predicted, SpO2 =92% at 750 m                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Born, raised and currently living at low altitude  │ Born, raised and currently living at low altitude  │      99 │
│ (\<800m)                                           │ (<800m)                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ COPD exacerbation, very severe COPD with hypoxemia │ COPD exacerbation, very severe COPD with hypoxemia │      99 │
│ at low altitude (FEV1/FVC \<0.7, FEV1 \<40%        │ at low altitude (FEV1/FVC <0.7, FEV1 <40%          │         │
│ predicted, oxygen saturation on room air \<92% at  │ predicted, oxygen saturation on room air <92% at   │         │
│ 750 m)                                             │ 750 m)                                             │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                           │   Score │
╞═══════════════════════════════════╪═════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Male and female patients, age 18-75 yrs │      47 │
├───────────────────────────────────┼─────────────────────────────────────────┼─────────┤
│ Must have maximum age of 75 Years │ Male and female patients, age 18-75 yrs │      47 │
╘═══════════════════════════════════╧═════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 95
Average Levenshtein Ratio of individual lines: 89.1
OverAll Ratio: 92.05
